7. Other income / expenses, net 

“Other income / expenses, net” in the 2017 / 18 financial year amounts to CHF 7.2 million (previous year CHF 6.3 million). The regular and systematic assessment of the provision for product liabilities in the Cochlear implants segment led to a release of CHF 1.8 million (previous year CHF 37.4 million). In addition, the divestment of two minor group companies in the EMEA region and the sale of one company in the USA led to a gain of CHF 5.5 million (previous year other income from divestments CHF 3.8 million). Furthermore in 2016 / 17 the "other expenses" also included an impairment of previously capitalized development costs of CHF 35.6 million. For further information refer to Note 2.7 “Provision for product liabilities”, Note 20 “Intangible assets”, Note 21 “Provisions” and Note 27 "Acquisitions/Disposals of subsidiaries".